Clinical Trials Browser

Phase 2 × OTHER_GOV × Folfox protocol × Clear all

NCT03939962 2022-01-26

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02845908 2021-04-23

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT04155671 2019-11-07

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms